CoLabs Int’l, Corp. (CLLB)

CoLabs Int’l was planning to go public, but the IPO was withdrawn on Jan 30, 2024.
IPO Price
Shares Offered
Deal Size
Chart not available yet
Data will show when the stock starts trading.
Market Cap 152.53M
Revenue (ttm) 157,000
Net Income (ttm) -6.56M
Shares Out 33.90M
EPS (ttm) -0.19
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Open n/a
Previous Close n/a
Day's Range n/a
52-Week Range n/a
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About CLLB

CoLabs Int’l is an over-the-counter pharmaceutical company with multi-market applications for our revolutionary targeted drug delivery system which is identified as QuantaSphere® Technology. We currently hold 29 issued patents and have an additional 15 patent applications pending. Our technology places OTC drugs, pharmaceuticals, and chemicals into micro-sized, electrostatically charged encapsulates as well as into other types of micro-encapsulates. These encapsulates are then suspended in uniquely designed formulations. This formulation of a h... [Read more]

Sector Healthcare
Founded 2008
Employees 4
Stock Exchange NASDAQ
Ticker Symbol CLLB
Full Company Profile

Financial Performance

Financial Statements


CoLabs Int’l IPO Registration Document (S-1)

CoLabs Int’l has filed to go public with an IPO on the NASDAQ.

1 year ago - SEC